AGENDA AT A GLANCE
Pre-Conference Day One
Tuesday, September 5 2023
Deep-Dive Workshop
Creating a Workplace Where Everyone Belongs: Unlocking the Value of Equity, Diversity & Inclusion to Transform Your Organization
News & Brews in Partnership with Roche
Updates In Oncology & Beyond: Featuring Voices From the Industry
Pre-Conference Day Two
Wednesday, September 6 2023
10:00 am | Deep-Dive Workshop in Partnership with Foundation Medicine
Leverage MRD in your Drug Development & Therapy Commercialization Strategies
2:00 pm | Deep-Dive Workshop In Partnership with Guardant Health
6:00 pm | Thought Leadership Engager in Partnership with Quest
Main Conference Day One - Thursday, September 7
Keynote Plenary Session: Providing Updates on the Current Framework for CDx Development to Facilitate Approvals & Applications
Reimagining Equity, Diversity & Inclusion (ED&I) in Clinical Trials to Improve Accessibility
Track A: Biomarker Discovery & Translational Development
Track B: Clinical Biomarker Development
Track C: CDx Development & Commercialization
Leveraging Digital Pathology for Biomarker Identification to Revolutionize Patient Stratification
Ensuring Robust Clinical Outcomes Using Endpoints to Define Patient Benefits
Exploring Strategic Guidelines to Implement CDx Assays in Clinical Trials for Successful Applications of CDx Tests
Ensuring Robust Pre-Clinical Analysis to Facilitate Translational Development
Assessing Safety & Efficacy of ctDNA for Improved Immunotherapies
Addressing Global Regulatory & Commercial Considerations to Inform the Future of Diagnostics
Keynote Plenary Session: Navigating the Ever-Changing CDx Landscapes to Ensure Stakeholder Alignment & Wide-Spread Accessibility
Main Conference Day Two - Friday, September 8
Keynote Plenary Session: Navigating the Ever-Changing CDx Landscapes to Ensure Stakeholder Alignment & Wide-Spread Accessibility
Track A: Biomarker Discovery & Translational Development
Track B: Clinical Biomarker Development
Track C: CDx Development & Commercialization
Examining Trends in Spatial & Multimodal Modelling to Transform Biomarker Discovery
Defining & Identifying Patient Populations Using Biomarker Data to Validate Clinical Development
Bridging Data Approaches to Achieve Faster Screening & Diagnosis for Accelerated Precision Medicine Treatments
Evaluating the Promise of Multi-Omics in Revolutionizing Biomarker Data for Precision Medicine
Utilizing Novel Tools & Technologies to Drive Diagnosis & Validation of Biomarkers
Exploring Current Guidelines to Drive Drug-Dx Co-Development & Efficient Trial Design for Fast-Tracked Market Access